CXCL9

CXCL9 Full Name

chemokine (C-X-C motif) ligand 9

CXCL9 Introduction

C-X-C Motif Chemokine Ligand 9 (CXCL9), historically known as Monokine Induced by Interferon-gamma (MIG), is a small, inducible cytokine belonging to the CXC chemokine family. Its defining feature is the presence of a characteristic amino acid sequence (the ELR motif) preceding the first cysteine residue. The expression of the CXCL9 gene is potently and primarily induced by interferon-gamma (IFN-γ). It is secreted by a variety of cells, including activated macrophages, dendritic cells, endothelial cells, and keratinocytes, in response to pro-inflammatory stimuli. This strong link to IFN-γ makes CXCL9 a classic marker for Th1-type immune responses and cell-mediated immunity.

Figure 1. Role and regulation of CXCL9 in cancer. (Source: Ding Q, 2016)

Mechanism of Action and Primary Biological Function
The primary function of CXCL9 is to act as a chemoattractant for activated T lymphocytes, particularly those expressing the CXC chemokine receptor 3 (CXCR3). Upon binding to CXCR3 on the surface of target immune cells, CXCL9 initiates a G-protein-coupled signaling cascade. This leads to actin polymerization, cytoskeletal rearrangement, and directional migration of these cells towards the source of the chemokine gradient. Therefore, its core biological role is to orchestrate the recruitment of CXCR3+ effector T cells, natural killer (NK) cells, and other leukocytes to sites of infection, inflammation, or tissue damage, amplifying the local adaptive immune response.

Role in Immune Defense and Pathological Conditions
CXCL9 plays a crucial role in host defense against intracellular pathogens (e.g., viruses, certain bacteria) and in anti-tumor immunity by directing cytotoxic lymphocytes to the site of threat. However, its dysregulated expression is a double-edged sword and contributes to the pathogenesis of numerous chronic inflammatory and autoimmune diseases. Persistently high levels of CXCL9 are implicated in diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease (IBD), and multiple sclerosis, where it sustains the influx of inflammatory cells, leading to tissue destruction. In organ transplantation, its expression is associated with T cell-mediated allograft rejection.

Alternate Names for CXCL9

CXCL9; chemokine (C-X-C motif) ligand 9; CMK; MIG; Humig; SCYB9; crg-10; C-X-C motif chemokine 9; small-inducible cytokine B9; gamma-interferon-induced monokine; monokine induced by gamma interferon; monokine induced by interferon-gamma;

• 1.Ding Q, Lu P, Xia Y, et al. CXCL9: evidence and contradictions for its role in tumor progression. Cancer medicine, 2016, 5(11): 3246-3259.